Skip to content

Waste the Waist: Pilot study for a randomised controlled trial of a pragmatic, primary care based intervention to support lifestyle change in the management of high cardiovascular risk

Waste the Waist: Pilot study for a randomised controlled trial of a pragmatic, primary care based intervention to support lifestyle change in the management of high cardiovascular risk

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10707899
Enrollment
100
Registered
2012-02-14
Start date
2011-03-16
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease Circulatory System Cardiovascular disease, unspecified

Interventions

The sample size is calculated to provide realistic estimates (and confidence intervals (CIs)) for the recruitment and study completion rates. The resulting sample size will also allow realistic estima

Sponsors

Bath and North East Somerset Primary Care Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 40-74 2. BMI 30 or more (27.5 for S. Asians, if ethnicity is known) 3. A ten year cardiovascular risk score of 20% or more (calculated using either the Framingham or QRISK method) 4. IGT - Impaired glucose tolerance (2 hour glucose on IGT test of 7.8 to 11.0 mmol/l) 5. IFG - Impaired fasting plasma glucose (6.1 to 6.9mmol/l.) 6. Male and female participants If recruitment proves difficult using the above criteria, we will search practice databases for people with higher risk obesity, defined as having a Body Mass Index of 30 or more plus either hypertension, hypercholesterolemia, family history of diabetes or heart disease, history of gestational diabetes, or polycystic ovary syndrome.

Exclusion criteria

Exclusion criteria: 1. People with existing heart disease or type 2 diabetes 2. People who are currently pregnant 3. People currently using weight loss drugs (which will interfere with planned measures) 4. People not fluent in English 5. Anyone who, in their GP?s opinion, has other conditions that would prevent engagement with the programme (including terminal illness, major mental health problems, communication difficulties requiring translation)

Design outcomes

Primary

MeasureTime frame
Recruitment rate measured at baseline

Secondary

MeasureTime frame
1. All measures proposed for the main trial (e.g. weight) will be taken and variance explored at 0, 4, and 12 months 2. Intervention concordance (the proportion attending >=4 of the 7 sessions) measured at 8 months 3. Study completion rate measure at 12 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 18, 2026